slide1

BRIDGING SCIENCE AND PATIENTS

Bridge Biotherapeutics is committed to restoring and improving the lives of patients by developing novel compounds into innovative new drugs through rigorous global clinical development processes.

slide2

BRIDGING SCIENCE AND PATIENTS

Bridge Biotherapeutics is committed to restoring and improving the lives of patients by developing novel compounds into innovative new drugs through rigorous global clinical development processes.

slide3

BRIDGING SCIENCE AND PATIENTS

Bridge Biotherapeutics is committed to restoring and improving the lives of patients by developing novel compounds into innovative new drugs through rigorous global clinical development processes.

개발 파이프라인

MEDIA

IR NOTICE & IR CENTER

STOCK PRICE

MORE
Share Price
13,800 won
Price Change
300
% Change
+2.22%
Turnover
39,210

PARTNER&CRO&CDMO